The abstract is read at the publisher; the summary is JClub's.
E2F3 generates two major isoforms, E2F3A and E2F3B, whose N-terminal differences are linked to overlapping and isoform-specific roles in cell cycle control and oncogenesis.
- Why it matters: Conflicting findings about whether E2F3A activates and E2F3B represses transcription have left uncertainty about how isoform timing, stability, and targets shape proliferation, differentiation, and cancer.
- What they did: This review synthesizes evidence on E2F3A versus E2F3B, focusing on how temporal expression, protein stability, and target gene specificity—and experimental limitations—affect interpretation.
- The result: Clarifying isoform-specific functions is proposed to help resolve open questions in cell cycle regulation, differentiation, and cancer biology where E2F3 is implicated.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.